IP Library Granted Patent US 10,980,565
Granted Patent B2
US 10,980,565 · App. 16/432,669 · Granted Apr 20, 2021

Method for ablating body tissue

Inventors: Hira V. Thapliyal (Los Altos, CA); David A. Gallup (Alameda, CA); James W. Arenson (Woodside, CA)
Assignee: Auris Health, Inc.
A61B17/320068A61B18/1492A61N7/02A61N7/022A61B17/2202A61B18/24A61B2017/003A61B2017/00106A61B2017/00243A61B2017/22024A61B2017/320069A61B2018/00029A61N2007/0078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,980,565
App. No.
16/432,669
Granted
Apr 20, 2021
Kind
B2
Abstract

A cardiac ablation method including the following steps: inserting a treatment catheter into an atrium of a heart, the treatment catheter including an ultrasound emitter; positioning the ultrasound emitter to face heart tissue within the left atrium outside of a pulmonary vein; emitting ultrasound energy from the ultrasound emitter while rotating the ultrasound emitter about a rotation axis; and ablating heart tissue with the ultrasound energy to form a lesion outside of a pulmonary vein.

Claims (25)

1. A tissue ablation system for creating a transmural lesion, the system comprising:

an ablation catheter comprising a proximal portion, a distal portion, and an ultrasound transducer disposed within the distal portion and is adapted to direct a collimated beam of ultrasound energy to a target tissue;

wherein the ultrasound transducer is adapted to operate in an ablation mode and a diagnostic mode;

wherein, in the ablation mode, the collimated beam of ultrasound energy is adapted to create a lesion in the target tissue to thereby ablate the target tissue; and

wherein, in the diagnostic mode, the ultrasound transducer is configured to act as a sensor to sense information about the target tissue based on a reflected ultrasound signal that is reflected back towards the ultrasound transducer by the target tissue;

a control mechanism operably coupled to the ablation catheter and adapted to rotate, translate, or bend the distal potion of the ablation catheters in order to sweep the collimated beam of ultrasound energy along an ablation path; and

a processor configured to adjust the sweep of the collimated beam of ultrasound energy based on the based on the sensed information to assure that the lesion is a transmural lesion.

2. The system of claim 1 , wherein the control mechanism is manually operated by a user.

3. The system of claim 1 , wherein the control mechanism is operated by a processor.

4. The system of claim 1 , wherein the ablation catheter is configured to regularly, on a time-shared basis, convert from the ablation mode briefly to the diagnostic mode to sense information about the target tissue.

5. The system of claim 1 , wherein a sweep rate of the collimated beam of ultrasound energy along the ablation path is configured to allow sufficient time for the lesion to develop.

6. The system of claim 1 , wherein the reflected ultrasound signal comprises an amplitude, wherein the amplitude depends on the type of target tissue sensed.

7. The system of claim 1 , wherein the sensed information comprises a residual tissue depth of the target tissue that has not been ablated.

8. The system of claim 1 , further comprising a generator operably coupled to the ultrasound transducer, wherein the generator is configured to automatically shut off if the sensed information indicates that the lesion is too deep into the target tissue.

9. The system of claim 1 , wherein the processor is configured to translate the distal portion of the ablation catheter to ensure that the ultrasound transducer is close enough to a surface of the target tissue for all movement throughout a cardiac cycle such that the entire movement is within a range for formation of the transmural lesion.

10. The system of claim 1 , further comprising a bending mechanism coupled to the ablation catheter and configured to bend the distal portion of the ablation catheter.

11. The system of claim 10 , wherein the bending mechanism comprises at least one pullwire, and wherein actuation of the at least one pullwire bends the distal portion of the ablation catheter.

12. The system of claim 10 , wherein the processor is connected to stepping motors operatively coupled to the control mechanism and the bending mechanism.

13. The system of claim 12 , wherein the processor is configured to control bending of the distal portion of the ablation catheter based on the sensed information.

14. The system of claim 1 , wherein the processor is configured to adjust a power delivered to the ultrasound transducer based on the sensed information.

15. The system of claim 1 , wherein the ablation catheter comprises a lumen through which a fluid is delivered to cool the ultrasound transducer.

16. The system of claim 1 , wherein the ultrasound transducer comprises a circular flat disc of less than 2.5 mm in diameter which is coated with a thin layer of metal and is adapted to produce more than 10 W of acoustic power output.

17. The system of claim 1 , further comprising a guide sheath through which the ablation catheter is delivered.

18. The system of claim 17 , wherein the ablation catheter is configured to translate and rotate relative to the guide sheath.

19. The system of claim 1 , wherein the ablation catheter comprises an inner catheter comprising, the ultrasound transducer and an outer catheter, and wherein the inner catheter is slidably disposed within the outer catheter.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2020
From: VYTRONUS, INC.
To: AURIS HEALTH, INC.
Reel/Frame 052871/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2019
From: THAPLIYAL, HIRA V.; GALLUP, DAVID A.; ARENSON, JAMES W.
To: VYTRONUS, INC.
Reel/Frame 050443/0888 →